Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.710
-0.020 (-1.16%)
Apr 30, 2026, 3:00 PM CST

Kangmei Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
23,64726,41332,44125,78730,50142,839
Market Cap Growth
-19.16%-18.58%25.81%-15.46%-28.80%221.38%
Enterprise Value
22,62725,38931,91824,90428,79776,028
Last Close Price
1.711.912.341.862.203.09
PE Ratio
2289.642557.443783.85251.53-5.41
Forward PE
-2.562.562.562.562.56
PS Ratio
4.505.036.255.297.3010.32
PB Ratio
3.233.614.503.644.374.30
P/TBV Ratio
3.463.864.874.004.834.64
P/FCF Ratio
-----1006.12
P/OCF Ratio
212.38237.22---199.99
PEG Ratio
-0.530.530.530.530.53
EV/Sales Ratio
4.314.836.155.116.8918.31
EV/EBITDA Ratio
54.5865.19-52.89--
EV/EBIT Ratio
202.60227.33-138.67--
EV/FCF Ratio
-214.04----1785.59
Debt / Equity Ratio
0.030.030.020.040.040.02
Debt / EBITDA Ratio
0.440.44-0.49--
Debt / FCF Ratio
-----4.82
Net Debt / Equity Ratio
-0.14-0.14-0.12-0.11-0.18-0.22
Net Debt / EBITDA Ratio
-2.71-2.716.36-1.701.700.89
Net Debt / FCF Ratio
9.999.991.711.921.56-51.99
Asset Turnover
0.390.390.370.330.270.17
Inventory Turnover
1.771.771.761.541.260.91
Quick Ratio
0.780.780.740.690.821.00
Current Ratio
1.261.261.171.121.361.68
Return on Equity (ROE)
0.17%0.17%0.17%1.47%-31.78%-
Return on Assets (ROA)
0.52%0.52%-1.84%0.76%-4.17%-7.71%
Return on Invested Capital (ROIC)
0.52%0.51%-2.28%2.80%-15.42%-31.95%
Return on Capital Employed (ROCE)
1.40%1.40%-5.20%2.20%-10.70%-27.40%
Earnings Yield
0.04%0.04%0.03%0.40%-8.81%18.48%
FCF Yield
-0.45%-0.40%-1.51%-1.62%-2.62%0.10%
Payout Ratio
--8.75%--0.17%
Buyback Yield / Dilution
-3.25%-3.25%-39.38%27.54%-1.85%-0.55%
Total Shareholder Return
-3.25%-3.25%-39.38%27.54%-1.85%-0.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.